The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence

被引:4
作者
Liu, Youjun [1 ]
Chen, Huanshi [1 ]
Chen, Tong [1 ]
Qiu, Guowen [1 ]
Han, Yu [2 ]
机构
[1] Liuzhou Municipal Liutie Cent Hosp, Dept Spinal Surg, Liuzhou, Peoples R China
[2] Zhengzhou Univ, Dept Orthoped, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
osteoclasts; bone metastasis; antiresorptive drugs; therapeutic targets; targeted therapy; BREAST-CANCER PATIENTS; ADJUVANT ZOLEDRONIC ACID; PLACEBO-CONTROLLED TRIAL; SKELETAL-RELATED EVENTS; ORAL SODIUM CLODRONATE; PHASE-III TRIAL; DOUBLE-BLIND; CATHEPSIN-K; SRC KINASE; OPEN-LABEL;
D O I
10.3389/fonc.2024.1445025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The occurrence of bone metastasis is a grave medical concern that substantially impacts the quality of life in patients with cancer. The precise mechanisms underlying bone metastasis remain unclear despite extensive research efforts, and efficacious therapeutic interventions are currently lacking. The ability of osteoclasts to degrade the bone matrix makes them a crucial factor in the development of bone metastasis. Osteoclasts are implicated in several aspects of bone metastasis, encompassing the formation of premetastatic microenvironment, suppression of the immune system, and reactivation of quiescent tumor cells. Contemporary clinical interventions targeting osteoclasts have proven effective in mitigating bone-related symptoms in patients with cancer. This review comprehensively analyzes the mechanistic involvement of osteoclasts in bone metastasis, delineates potential therapeutic targets associated with osteoclasts, and explores clinical evidence regarding interventions targeting osteoclasts.
引用
收藏
页数:16
相关论文
共 162 条
[111]   Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer [J].
Saarto, Tiina ;
Vehmanen, Leena ;
Blomqvist, Carl ;
Elomaa, Inkeri .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (26) :4289-4295
[112]   Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer [J].
Safarzadeh, Elham ;
Hashemzadeh, Shahryar ;
Duijf, Pascal H. G. ;
Mansoori, Behzad ;
Khaze, Vahid ;
Mohammadi, Ali ;
Kazemi, Tohid ;
Yousefi, Mehdi ;
Asadi, Milad ;
Mohammadi, Hamed ;
Babaie, Farhad ;
Baradaran, Behzad .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) :3515-3525
[113]   Mechanisms of bone development and repair [J].
Salhotra, Ankit ;
Shah, Harsh N. ;
Levi, Benjamin ;
Longaker, Michael T. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (11) :696-711
[114]   De novo steroidogenesis in tumor cells drives bone metastasis and osteoclastogenesis [J].
Sandor, Luca F. ;
Huh, Joon B. ;
Benko, Peter ;
Hiraga, Toru ;
Poliska, Szilard ;
Dobo-Nagy, Csaba ;
Simpson, Joanna P. ;
Homer, Natalie Z. M. ;
Mahata, Bidesh ;
Gyori, David S. .
CELL REPORTS, 2024, 43 (03)
[115]   Myeloid-Derived Suppressor Cells as Osteoclast Progenitors: A Novel Target for Controlling Osteolytic Bone Metastasis [J].
Sawant, Anandi ;
Ponnazhagan, Selvarangan .
CANCER RESEARCH, 2013, 73 (15) :4606-4610
[116]   Depletion of Plasmacytoid Dendritic Cells Inhibits Tumor Growth and Prevents Bone Metastasis of Breast Cancer Cells [J].
Sawant, Anandi ;
Hensel, Jonathan A. ;
Chanda, Diptiman ;
Harris, Brittney A. ;
Siegal, Gene P. ;
Maheshwari, Akhil ;
Ponnazhagan, Selvarangan .
JOURNAL OF IMMUNOLOGY, 2012, 189 (09) :4258-4265
[117]   Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline [J].
Saylor, Philip J. ;
Rumble, R. Bryan ;
Tagawa, Scott T. ;
Eastham, James A. ;
Finelli, Antonio ;
Reddy, Pavan S. ;
Kungel, Terry M. ;
Nissenberg, Merel G. ;
Michalski, Jeff .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15) :1736-+
[118]   Phase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622 [J].
Schott, Anne F. ;
Barlow, William E. ;
Van Poznak, Catherine H. ;
Hayes, Daniel F. ;
Moinpour, Carol M. ;
Lew, Danika L. ;
Dy, Philip A. ;
Keller, Evan T. ;
Keller, Jill M. ;
Hortobagyi, Gabriel N. .
BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) :87-95
[119]   Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance) [J].
Shapiro, Charles L. ;
Moriarty, James P. ;
Dusetzina, Stacie ;
Himelstein, Andrew L. ;
Foster, Jared C. ;
Grubbs, Stephen S. ;
Novotny, Paul J. ;
Borah, Bijan J. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (35) :3949-+
[120]   CCR5 Receptor Antagonists Block Metastasis to Bone of v-Src Oncogene-Transformed Metastatic Prostate Cancer Cell Lines [J].
Sicoli, Daniela ;
Jiao, Xuanmao ;
Ju, Xiaoming ;
Velasco-Velazquez, Marco ;
Ertel, Adam ;
Addya, Sankar ;
Li, Zhiping ;
Ando, Sebastiano ;
Fatatis, Alessandro ;
Paudyal, Bishnuhari ;
Cristofanilli, Massimo ;
Thakur, Mathew L. ;
Lisanti, Michael P. ;
Pestell, Richard G. .
CANCER RESEARCH, 2014, 74 (23) :7103-7114